http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Article/list/9397 Treatment and research news and developments about urinary incontinence, overactive bladder, and other voiding dysfunctions. 2009-11-21T20:31:35Z http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Research-points-to-expanding-role-of-botulinum-tox/ArticleStandard/Article/detail/637943?contextCategoryId=9397&ref=25 In this interview, Michael B. Chancellor, MD, discusses using botulinum toxin for treating overactive bladder, BPH, interstitial cystitis, and other conditions. 2009-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/442009/637943null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Majority-of-nocturia-patients-have-nocturnal-polyu/ArticleStandard/Article/detail/637925?contextCategoryId=9397&ref=25 A study shows that most patients with nocturia have nocturnal polyuria, which is consistent with other studies showing that overproduction of urine at night is a major contributory factor to nocturia in about 80% of patients. 2009-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/442009/637925null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Majority-of-nocturia-patients-have-nocturnal-polyu/ArticleStandard/Article/detail/638690?contextCategoryId=9397&ref=25 Drs. Shlomo Raz and Ja-Hong Kim discuss recent advances in the treatment of stress incontinence. 2009-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452009/638690null REMOTE http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Nerve-growth-factor-level-may-be-marker-for-neurog/ArticleStandard/Article/detail/637937?contextCategoryId=9397&ref=25 Nerve growth factor levels in urine could prove a useful biomarker for interstitial cystitis/painful bladder syndrome and neurogenic overactive bladder. 2009-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/442009/637937null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Multidrug-therapy-effective-in-neurogenic-bladder/ArticleStandard/Article/detail/637945?contextCategoryId=9397&ref=25 Alpha-blockers, tricyclic antidepressants, or both can improve compliance, lower pressures at bladder capacity, and improve reflux, incontinence, and detrusor overactivity in neurogenic bladder patients. 2009-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/442009/637945null XML http://urologytimes.modernmedicine.com/urologytimes/Inflammation+and+Infection/Research-points-to-expanding-role-of-botulinum-tox/ArticleStandard/Article/detail/638689?contextCategoryId=9397&ref=25 In this podcast, Dr. Phil Hanno interviews Dr. Michael Chancellor on the potential role of botulinum toxin in urology. 2009-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452009/638689null REMOTE http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Surgery-for-incontinence-The-pendulum-has-swung/ArticleStandard/Article/detail/637922?contextCategoryId=9397&ref=25 Over the course of a decade, the therapeutic pendulum in treating urinary incontinence in women swung dramatically from needle suspension and anterior urethropexy to collagen injections and back again to suspension procedures with no sound clinical trials driving the move to either approach. 2009-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/442009/637922null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Transvaginal-mesh-Further-study-of-risks-benefits-/ArticleStandard/Article/detail/614297?contextCategoryId=9397&ref=25 It's not clear yet whether transvaginal mesh offers superior anatomic or symptomatic outcomes compared to traditional apical suspension repairs. 2009-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/312009/614297null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Bowel-symptoms-are-prevalent-in-refractory-OAB/ArticleStandard/Article/detail/614284?contextCategoryId=9397&ref=25 Most women who undergo sacral neuromodulation for refractory overactive bladder report concomitant bowel symptoms when asked. 2009-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/312009/614284null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Botulinum-treatment-improves-quality-of-life-in-pa/ArticleStandard/Article/detail/606043?contextCategoryId=9397&ref=25 Injection of botulinum toxin A (Botox) is associated with improvement in patient-reported quality of life in the treatment of idiopathic overactive bladder. 2009-07-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/262009/606043null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Topical-overactive-bladder-gel-found-well-tolerate/ArticleStandard/Article/detail/606037?contextCategoryId=9397&ref=25 In a pivotal phase III clinical trial, oxybutynin chloride gel 10% (Gelnique) was well tolerated and effective in improving symptoms in women with overactive bladder. 2009-07-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/262009/606037null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Neobladder-may-restore-function-in-neurogenic-blad/ArticleStandard/Article/detail/606044?contextCategoryId=9397&ref=25 Researchers reported 1-year data on augmenting the bladders of patients with spina bifida using neobladder developed from the patients' own cells. 2009-07-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/262009/606044null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Instillation-cocktail-appears-safe-effective-in-ov/ArticleStandard/Article/detail/606048?contextCategoryId=9397&ref=25 Direction instillation of a solution containing botulinum toxin A (Botox) and dimethyl sulfoxide (DMSO [Rimso-50]) appears to be a safe and potentially promising method of treating women with voiding dysfunction and associated detrusor overactivity. 2009-07-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/262009/606048null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Male-sling-shows-efficacy-for-SUI-post-RP-post-RT/ArticleStandard/Article/detail/595555?contextCategoryId=9397&ref=25 A newer retro-urethral male sling is a safe and minimally invasive treatment for male stress urinary incontinence after radical prostatectomy that yields reproducible and stable results after 12 months, according to study findings presented at the European Association of Urology annual congress. 2009-05-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/182009/595555null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/SUI-agent-shows-elevated-rate-of-abscess/ArticleStandard/Article/detail/595564?contextCategoryId=9397&ref=25 A study conducted by researchers from the United Kingdom has confirmed earlier reports of significant complications associated with the use of an injectable agent for the treatment of SUI. 2009-05-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/182009/595564null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Advanced-techniques-aim-to-aid-continence/ArticleStandard/Article/detail/593044?contextCategoryId=9397&ref=25 In the next few years, expect a plethora of new tools for managing OAB, stress and urge incontinence, and neurogenic bladder. 2009-04-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/152009/593044null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Weight-loss-may-restore-continence-in-obese-women/ArticleStandard/Article/detail/591100?contextCategoryId=9397&ref=25 By losing just 8% of their total body weight, overweight and obese women can significantly reduce the frequency of urinary incontinence episodes, according to results of a multicenter trial. 2009-04-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142009/591100null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Pre-radical-prostatectomy-leakage-pad-use-predicts/ArticleStandard/Article/detail/584390?contextCategoryId=9397&ref=25 Baseline urinary continence status, based on a strict definition of no leakage or pad use, is predictive of improved return of continence following radical prostatectomy, according to University of Chicago researchers. 2009-03-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/102009/584390null XML http://urologytimes.modernmedicine.com/urologytimes/Enews/Obese-women-can-add-reduced-incontinence-to-benefi/ArticleStandard/Article/detail/580975?contextCategoryId=9397&ref=25 Behavioral weight-loss programs can be effective for reducing urinary incontinence in women who are overweight or obese, according to a study published in the New England Journal of Medicine (2009; 360:481-90). 2009-02-12T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/072009/580975null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Urologic-Diseases-project-enters-bold-second-phase/ArticleStandard/Article/detail/567565?contextCategoryId=9397&ref=25 In this interview, Mark S. Litwin, MD, MPH discusses the NIDDK-funded Urologic Diseases in America (UDA) project, which is now in its second phase. 2008-12-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/472008/567565null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Sexual-function-improves-after-stress-urge-inconti/ArticleStandard/Article/detail/567564?contextCategoryId=9397&ref=25 Sexual function improves in women after successful surgery for stress urinary incontinence whether they undergo a sling procedure or Burch colpopsuspension. 2008-12-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/472008/567564null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Neurostimulation-in-urology-Untapped-potential/ArticleStandard/Article/detail/563890?contextCategoryId=9397&ref=25 Dr. Tanagho, professor emeritus of urology at the University of California, San Francisco, discusses the history of neurostimulation in urology, its current applications, and possible future directions. 2008-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452008/563890null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Post-radical-prostatectomy-incontinence-How-to-con/ArticleStandard/Article/detail/563891?contextCategoryId=9397&ref=25 Many post-prostatectomy incontinence patients have concomitant sphincteric and bladder dysfunctions. 2008-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452008/563891null XML http://www.modernmedicine.com/modernmedicine/Surgery/Neural-stimulation-anticholinergic-comparable-in-o/ArticleStandard/Article/detail/557214?contextCategoryId=9397&ref=25 In overactive bladder, percutaneous tibial nerve stimulation performs just as well as well as the most frequently prescribed drug. 2008-10-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/412008/557214null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Tension-free-vaginal-tape-sling-Outcomes-depend-on/ArticleStandard/Article/detail/553499?contextCategoryId=9397&ref=25 Getting good results with the minimally invasive TVT SECUR vaginal sling for stress urinary incontinence may be a matter of technique. 2008-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/392008/553499null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Obesity-aging-swell-prevalence-of-lower-urinary-tr/ArticleStandard/Article/detail/553512?contextCategoryId=9397&ref=25 Prevalence of symptoms is influenced by adiposity, but in different ways in men and women, suggesting a different pathophysiology of LUTS in men and women. 2008-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/392008/553512null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Overactive-bladder-dry-patients-benefit-from-lower/ArticleStandard/Article/detail/553500?contextCategoryId=9397&ref=25 When oral antimuscarinic therapy fails for overactive bladder patients who don't leak, intra-detrusor botulinum toxin A (Botox) injection is effective, and costs can be kept down with a lower dose. 2008-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/392008/553500null XML http://www.modernmedicine.com/modernmedicine/Pediatric+Urology/Bladder-control-within-reach-afer-spinal-injury/ArticleStandard/Article/detail/543670?contextCategoryId=9397&ref=25 Pediatric urologists have confirmed that environmental pollutants can impair male sexual development and fertility and that reinnervation of the bladder after spinal cord injury may be within reach. 2008-08-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/342008/543670null XML http://urologytimes.modernmedicine.com/urologytimes/Enews/CMS-policy-opens-access-to-single-use-catheters/ArticleStandard/Article/detail/525999?contextCategoryId=9397&ref=25 Patients on intermittent catheterization are now allowed up to 200 single-use, disposable catheters per month, thanks to a change in policy by the Centers for Medicare & Medicaid Services. The decision provides improved access to single-use catheters in patients with multiple sclerosis, spinal cord injuries, and spina bifida. 2008-06-26T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/262008/525999null HTML http://urologytimes.modernmedicine.com/urologytimes/Enews/FDA-accepts-NDA-for-topical-gel-formulation-for-OA/ArticleStandard/Article/detail/521122?contextCategoryId=9397&ref=25 A new drug application for a topical gel formulation of oxybutynin chloride in the treatment of overactive bladder has been accepted for filing by the FDA, according to Watson Pharmaceuticals, Inc., the manufacturer. 2008-06-05T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/232008/521122null HTML http://www.modernmedicine.com/modernmedicine/Inflammation+and+Infection/Studies-probe-pain-pathogen-origins-interactions/ArticleStandard/Article/detail/517412?contextCategoryId=9397&ref=25 In chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), two pivotal clinical trials "are going to have an immediate impact on the way you practice," said Anthony J. Schæffer, MD, professor and chairman of the department of urology at the Northwestern University Feinberg School of Medicine, Chicago. 2008-05-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/202008/517412null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Anticholinergic-drugs-may-increase-cognitive-decli/ArticleStandard/Article/detail/514991?contextCategoryId=9397&ref=25 Anticholinergic drugs may cause older people to experience greater decline in their thinking skills than people not taking the drugs, according to research presented at the American Academy of Neurology annual meeting in Chicago. 2008-05-08T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/192008/514991null HTML http://www.modernmedicine.com/modernmedicine/In+the+OR/Using-urethral-slings-to-manage-post-radical-prost/ArticleStandard/Article/detail/515202?contextCategoryId=9397&ref=25 Despite advances in surgical technique and the recent advent of laparoscopy and robotic assistance, urinary incontinence remains a real and potential problem for patients after radical prostatectomy. 2008-05-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/192008/515202null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Weight-gain-may-worsen-incontinence-symptoms/ArticleStandard/Article/detail/508492?contextCategoryId=9397&ref=25 In midlife women, worsening of incontinence symptoms does not appear to be attributable to the menopausal transition, according to a multicenter study. The study’s authors say that modifiable factors such as weight gain may be to blame (Obstet Gynecol 2008; 111:667-77). 2008-04-10T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/152008/508492null HTML http://www.modernmedicine.com/modernmedicine/Pediatric+Urology/Cerebral-palsy-incontinence-likely-due-to-underlyi/ArticleStandard/Article/detail/506904?contextCategoryId=9397&ref=25 Video urodynamic studies found serious underlying pathology in a majority of cerebral palsy children who had urinary incontinence. 2008-04-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142008/506904null XML http://www.modernmedicine.com/modernmedicine/Pediatric+Urology/Pediatric-refractory-urgency-neuropsychiatric-diso/ArticleStandard/Article/detail/506905?contextCategoryId=9397&ref=25 Children who do not respond to treatment for urgency frequency syndrome may have underlying neuropsychiatric disorders that need treatment before UFS symptoms can be resolved. 2008-04-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142008/506905null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/One-third-of-women-experience-pelvic-floor-disorde/ArticleStandard/Article/detail/502119?contextCategoryId=9397&ref=25 One-third of women appear to suffer from one or more pelvic floor disorders, researchers from Kaiser Permanente reported in Obstetrics & Gynecology (2008; 111:678-85). 2008-03-13T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/112008/502119null HTML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/NIH-Urinary-incontinence-stigma-still-hampers-trea/ArticleStandard/Article/detail/494604?contextCategoryId=9397&ref=25 An independent panel convened by the National Institutes of Health found that fewer than half of those experiencing urinary or fecal incontinence report their symptoms to health care providers without prompting, impairing their quality of life and hindering development of prevention and treatment strategies. 2008-02-28T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/092008/494604null HTML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Muscle-bladder-training-may-resolve-urinary-incont/ArticleStandard/Article/detail/494611?contextCategoryId=9397&ref=25 Pelvic floor muscle training plus bladder training appear to resolve urinary incontinence, according to a new systematic review of published studies on non-surgical management of urinary incontinence in women. 2008-02-28T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/092008/494611null HTML http://urologytimes.modernmedicine.com/urologytimes/BPH/Botulinum-toxin-may-trigger-severe-adverse-reactio/ArticleStandard/Article/detail/494609?contextCategoryId=9397&ref=25 FDA has received reports of systemic adverse reactions, including respiratory compromise and death following the use of botulinum toxins types A (Botox) and B (BotoMyobloc) for FDA-approved and unapproved uses. The reactions reported are suggestive of botulism, the agency said. 2008-02-28T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/092008/494609null HTML http://urologytimes.modernmedicine.com/urologytimes/Prostate+Cancer/Urinary-dysfunction-is-most-troubling-side-effect-/ArticleStandard/Article/detail/491170?contextCategoryId=9397&ref=25 Men with prostate cancer who undergo prostatectomy cite sexual dysfunction as the most common side effect after surgery, but urinary dysfunction troubles these patients most, a study from the University of Florida College of Nursing, Gainesville, has found. What’s more, many are not emotionally prepared to face these complications, according to the study, reported in Urologic Nursing (2007; 27:527-33). 2008-02-14T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/072008/491170null HTML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Adverse-events-higher-with-concomitant-SUI-surgery/ArticleStandard/Article/detail/489183?contextCategoryId=9397&ref=25 Patients undergoing surgical treatment for stress incontinence with concomitant surgical repair, including anterior or posterior/apical repair and other non-prolapse procedures, appear to be at higher risk for wound-related or genitourinary complications. 2008-02-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/062008/489183null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Botulinum-effective-in-refractory-urge-incontinenc/ArticleStandard/Article/detail/489184?contextCategoryId=9397&ref=25 Botulinum toxin A (Botox) is highly effective as a treatment for refractory urge incontinence symptoms in women with urodynamic evidence of detrusor overactivity incontinence, but patients require assessment for transient urinary retention. 2008-02-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/062008/489184null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/At-1-year-TOT-is-equalsuperior-to-TVT-in-stress-ur/ArticleStandard/Article/detail/489175?contextCategoryId=9397&ref=25 A recent multicenter study provides some justification for the increasing popularity of transobturator slings in the treatment of stress urinary incontinence in patients with and without concurrent pelvic organ prolapse. 2008-02-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/062008/489175null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Urge-symptoms-advanced-prolapse-raise-treatment-fa/ArticleStandard/Article/detail/489171?contextCategoryId=9397&ref=25 Women with greater baseline urge incontinence symptoms, those with more advanced pelvic organ prolapse, and postmenopausal women not on hormone replacement therapy (HRT) are all at greater risk for treatment failure when undergoing Burch and sling procedures for stress urinary incontinence. 2008-02-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/062008/489171/ut0208_CVR_thumbnail.gif http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/062008/489171null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Prolapse-repair-plus-Burch-improves-2-year-outcome/ArticleStandard/Article/detail/489174?contextCategoryId=9397&ref=25 Offering a concomitant Burch colposuspension to stress-continent women undergoing sacrocolpopexy not only appears to protect patients from later stress urinary incontinence, but it also may improve symptoms of urge incontinence above and beyond the effects of the prolapse repair alone. 2008-02-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/062008/489174null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Fistula-repair-improves-continence-after-prostate-/ArticleStandard/Article/detail/489182?contextCategoryId=9397&ref=25 A study supported the argument that the perineal approach and employment of the gracilis muscle should be the preferred approach for recto-urethral fistula repair. 2008-02-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/062008/489182null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Topical-gel-promising-for-overactive-bladder-patie/ArticleStandard/Article/detail/486691?contextCategoryId=9397&ref=25 An investigational topical treatment for overactive bladder produced a statistically significant reduction in incontinence episodes and a reduction in frequency, while increasing void volume compared with placebo in a phase III study of oxybutynin topical gel in patients with overactive bladder. 2008-01-31T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/042008/486691null HTML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/FDA-requests-new-prescribing-information-for-desmo/ArticleStandard/Article/detail/480232?contextCategoryId=9397&ref=25 The FDA has requested that manufacturers update the labels and prescribing information for tablet and intranasal formulations of desmopressin (DDAVP, Minirin, Stimate), used to treat pediatric nocturnal enuresis, to include important new information about the risk of severe hyponatremia and seizures. The action follows reports of 61 patients who experienced hyponatremia-related seizures linked to use of the drug, including two who died. 2007-12-20T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/512007/480232null HTML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/OAB-agents-Similar-in-efficacy-but-not-identical/ArticleStandard/Article/detail/475201?contextCategoryId=9397&ref=25 Agents in the pipeline but not yet approved are expected to expand the range of OAB treatment choices. 2007-12-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/482007/475201null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Hysterectomy-increases-risk-of-urinary-incontinenc/ArticleStandard/Article/detail/472507?contextCategoryId=9397&ref=25 Researchers at the Karolinska Institutet in Stockholm, Sweden, have shown that hysterectomy greatly increases the risk of urinary incontinence, and women who undergo the procedure are more than twice as likely to also undergo surgery for urinary incontinence (The Lancet 2007; 370:1494-9). 2007-11-15T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/462007/472507null HTML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Company-initiates-long-term-study-of-nerve-stimula/ArticleStandard/Article/detail/472511?contextCategoryId=9397&ref=25 Medtronic, Inc. has initiated the InSite Trial, a post-market study of its sacral nerve stimulation therapy (InterStim) for the treatment of overactive bladder and urinary retention. The FDA has approved this efficacy study, which aims to enroll more than 450 patients. Those who qualify will be randomized to receive either InterStim therapy or standard medical treatment, including oral medications, as determined by their physician. 2007-11-15T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/462007/472511null HTML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Slings-effective-safe-in-obese-incontinent-women/ArticleStandard/Article/detail/470536?contextCategoryId=9397&ref=25 No matter which sling surgeons use to treat incontinence in obese women, results are similar—and good—with minimal complications. 2007-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452007/470536null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Stem-cells-may-restore-continence-in-both-sexes/ArticleStandard/Article/detail/470531?contextCategoryId=9397&ref=25 Using stem cells to cure stress urinary incontinence has been tested against collagen bulking and in incontinence following prostate surgery, and has come up a winner. 2007-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452007/470531null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Data-on-stem-cell-injections-for-SUI-raise-key-que/ArticleStandard/Article/detail/470711?contextCategoryId=9397&ref=25 The authors of a study showing the potential value of ultrasound-guided stem cells as a standard treatment for stress urinary incontinence need to be commended on their results. 2007-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452007/470711null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Older-sling-patients-need-extra-counseling/ArticleStandard/Article/detail/470533?contextCategoryId=9397&ref=25 Older women who are candidates for sling surgery to treat stress incontinence need more intensive counseling than younger patients do. 2007-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452007/470533null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Differences-in-vaginal-prolapse-repair-treatment-w/ArticleStandard/Article/detail/470534?contextCategoryId=9397&ref=25 With a median 2 years of follow-up, anterior repair with porcine skin collagen mesh still looks better than plication alone, but not dramatically better, and the difference could lessen with longer-term follow-up. 2007-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452007/470534null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Symptoms-insufficient-for-urine-retention-diagnosi/ArticleStandard/Article/detail/470535?contextCategoryId=9397&ref=25 A study from Loyola University Medical Center posed a simple question: "Can a surgeon rely on obstructive symptoms to detect urinary retention?" The study results offered an equally simple answer: No. 2007-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452007/470535null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/OAB-therapy-appears-to-improve-sexual-quality-of-l/ArticleStandard/Article/detail/465639?contextCategoryId=9397&ref=25 Treatment with extended-release tolterodine tartrate (Detrol LA) is associated with higher sexual quality of life scores and reduced anxiety measurements in women with overactive bladder and urge urinary incontinence, according to a study presented at the American Urogynecologic Society annual scientific meeting in Hollywood, FL. 2007-10-18T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/422007/465639null HTML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Sacral-neuromodulation-affects-central-nervous-sys/ArticleStandard/Article/detail/465160?contextCategoryId=9397&ref=25 A new study has produced solid evidence that sacral neuromodulation affects the central nervous system. 2007-10-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/422007/465160null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Botulinum-toxin-in-overactive-bladder-The-site-mak/ArticleStandard/Article/detail/465151?contextCategoryId=9397&ref=25 Where botulinum toxin A (Botox) is injected to treat idiopathic detrusor overactivity makes a difference—not right away, but in the long term. 2007-10-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/422007/465151null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/FDA-approves-once-daily-treatment-for-overactive-b/ArticleStandard/Article/detail/449645?contextCategoryId=9397&ref=25 The FDA has approved trospium chloride extended-release capsules (Sanctura XL) for once-daily treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. 2007-08-17T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/332007/449645null HTML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/New-approaches-improve-incontinence-management/ArticleStandard/Article/detail/449572?contextCategoryId=9397&ref=25 The array of devices and procedures available to treat urinary incontinence and bladder dysfunction appears to be growing nonstop. 2007-08-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/332007/449572null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Autologous-cell-injections-may-benefit-women-with-/ArticleStandard/Article/detail/442332?contextCategoryId=9397&ref=25 Transurethral ultrasonography-guided injections of autologous myoblasts and fibroblasts appear to be effective in treating women with stress urinary incontinence, according to a study published in The Lancet (2007; 369:2179-86). 2007-07-19T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/292007/442332null HTML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Stem-cells-show-efficacy-durability-in-treating-SU/ArticleStandard/Article/detail/440056?contextCategoryId=9397&ref=25 Urinary incontinence can be effectively treated with ultrasonography-guided injections of autologous myoblasts and fibroblasts, with long-term results up to 4 years after treatment. 2007-07-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/282007/440056null XML http://www.modernmedicine.com/modernmedicine/News/Sling-shows-higher-overall-success-than-Burch-in-t/ArticleStandard/Article/detail/438775?contextCategoryId=9397&ref=25 Two-year results of the prospective, randomized Stress Incontinence Surgical Treatment Efficacy Trial (SISTEr) show significantly higher success rates in women who undergo the rectus fascial pubovaginal sling procedure compared to those in women who receive a Burch colposuspension. 2007-07-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/272007/438775null HTML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Voiding-complaints-common-in-women-having-SUI-surg/ArticleStandard/Article/detail/440052?contextCategoryId=9397&ref=25 Urologists who believe that women electing surgery for stress urinary incontinence (SUI) are unlikely to have voiding problems should re-examine their conclusions. 2007-07-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/282007/440052null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Study-Both-TOT-and-TVT-are-safe-effective/ArticleStandard/Article/detail/431393?contextCategoryId=9397&ref=25 Results of an Italian study comparing transobturator suburethral tape (TOT) and tension-free vaginal tape (TVT) show both surgical techniques to be equally efficient at a follow-up of nearly 3 years in women suffering from stress urinary incontinence. 2007-06-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/232007/431393null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Novel-incontinence-treatments-gain-credibility/ArticleStandard/Article/detail/427781?contextCategoryId=9397&ref=25 Developments in stem cell therapy, new minimally invasive sling procedures, and research on botulinum toxin (Botox) therapy for overactive bladder soon will give urologists far more effective treatment for incontinence than they can offer their patients today. 2007-05-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/202007/427781null XML http://urologytimes.modernmedicine.com/urologytimes/2007+Urology+Congress/Expert-Synthetic-materials-are-preferred-for-stres/ArticleStandard/Article/detail/417392?contextCategoryId=9397&ref=25 Synthetic materials work much better than biological ones for surgical treatment of stress urinary incontinence, in the experience of Shlomo Raz, MD, professor of urology at the University of California, Los Angeles. 2007-04-08T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142007/417392null HTML http://urologytimes.modernmedicine.com/urologytimes/2007+Urology+Congress/Current-OAB-agents-are-similar-but-not-identical/ArticleStandard/Article/detail/417136?contextCategoryId=9397&ref=25 Antimuscarinic agents are the primary pharmacologic therapies for overactive bladder, and their ranks continue to grow. The agents in this class—oxybutynin (Ditropan), tolterodine (Detrol), trospium (Sanctura), solifenacin (Vesicare), and darifenacin (Enablex)—are similar in efficacy and side effects, but not identical. 2007-04-06T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142007/417136null HTML http://urologytimes.modernmedicine.com/urologytimes/2007+Urology+Congress/New-OAB-therapies-are-on-the-way/ArticleStandard/Article/detail/417137?contextCategoryId=9397&ref=25 With seven approved drugs for overactive bladder already on the market, the potential for new treatments might seem to be limited. The reality is that OAB treatment is still not optimal. 2007-04-06T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142007/417137null HTML http://urologytimes.modernmedicine.com/urologytimes/Enews/Sling-for-stress-incontinence-in-women-receives-FD/ArticleStandard/Article/detail/416225?contextCategoryId=9397&ref=25 A new, less-invasive treatment for female stress urinary incontinence has garnered clearance from the FDA. 2007-04-04T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142007/416225null HTML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Expectations-guide-patients-view-of-incontinence-t/ArticleStandard/Article/detail/420450?contextCategoryId=9397&ref=25 Urinary incontinence patients' personal goals and expectations are more closely tied to their quality of life than is any objective measure of the disease, suggesting that treatment outcomes should be assessed in a more patient-focused manner. 2007-04-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/162007/420450null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Study-identifies-unique-subgroup-of-women-with-SUI/ArticleStandard/Article/detail/420460?contextCategoryId=9397&ref=25 Among women with stress incontinence and no signs of detrusor overactivity, there exists a significant subgroup with low voided volumes, high incidences of urgency and urge-related leaks, and relatively severe symptoms that can only be identified through careful evaluation. 2007-04-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/162007/420460null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/New-nerve-stim-approach-may-provide-option-in-OAB/ArticleStandard/Article/detail/420459?contextCategoryId=9397&ref=25 Dorsal genital nerve stimulation using a minimally invasive, pre-pubic approach appears to reduce the symptoms of overactive bladder and is well tolerated by patients, according to results of a prospective, multicenter feasibility study. 2007-04-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/162007/420459null XML http://urologytimes.modernmedicine.com/urologytimes/Enews/Muscle-damage-during-childbirth-is-linked-to-later/ArticleStandard/Article/detail/404640?contextCategoryId=9397&ref=25 A new study from the University of Michigan Health System establishes one of the strongest connections yet discovered between muscle damage that can occur during vaginal deliveries and pelvic organ prolapse, the authors say. 2007-02-15T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/072007/404640null HTML http://urologytimes.modernmedicine.com/urologytimes/BPH/Company-challenges-medical-community-to-validate-b/ArticleStandard/Article/detail/404645?contextCategoryId=9397&ref=25 Verathon, Inc. (Bothell, WA) has issued a challenge to urology researchers: The company is offering $10,000 for the most practical and scientifically valid protocol to study the relationship of bladder wall mass and overactive bladder or BPH. The goal is to determine how bladder wall mass measurements can best be used in clinical practice. 2007-02-15T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/072007/404645null HTML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Case-Studies-in-Voiding-Dysfunction/ArticleStandard/Article/detail/395072?contextCategoryId=9397&ref=25 A 63-year-old male with severe pelvic pain and difficulty voiding after undergoing male sling 2007-01-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/conturo/522006/395072null XML http://www.modernmedicine.com/modernmedicine/BPH/Combination-BPH-OAB-therapy-controls-symptoms/ArticleStandard/Article/detail/395018?contextCategoryId=9397&ref=25 New York—Men bothered by overactive bladder and prostate enlargement symptoms who are treated simultaneously with the anticholinergic drug tolterodine tartrate extended-release capsules (Detrol LA) and the alpha-blocker tamsulosin (Flomax) report better symptom control and quality of life than do men treated with either one of the medications or placebo, according to a recently published study (JAMA 2006; 296:2319-28). 2007-01-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/522006/395018null XML http://urologytimes.modernmedicine.com/urologytimes/Enews/OAB-drug-reduces-urgency-episodes-increases-warnin/ArticleStandard/Article/detail/393791?contextCategoryId=9397&ref=25 Patients with overactive bladder who are treated with solifenacin succinate (Vesicare) experience statistically significant reductions in episodes of urgency, suggests a study presented at the International Continence Society annual meeting in Christchurch, New Zealand. 2006-12-21T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/512006/393791null HTML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/The-male-sling-for-SUI-Indications-and-techniques/ArticleStandard/Article/detail/390276?contextCategoryId=9397&ref=25 The male sling achieves continence by unilateral ventral urethral compression that does not require patient activation, allowing volitional and spontaneous voiding. 2006-12-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/492006/390276null XML http://urologytimes.modernmedicine.com/urologytimes/Enews/Generic-versions-of-oxybutynin-gain-approval-for-O/ArticleStandard/Article/detail/385990?contextCategoryId=9397&ref=25 The FDA has granted approval to two generic versions of extended-release oxybutynin chloride for the treatment of overactive bladder. 2006-11-16T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/462006/385990null HTML http://urologytimes.modernmedicine.com/urologytimes/BPH/Combination-therapy-may-be-more-effective-for-LUTS/ArticleStandard/Article/detail/385981?contextCategoryId=9397&ref=25 Men with overactive bladder and lower urinary tract symptoms who receive combination therapy are more likely to report improvement in symptoms than those who receive only one medication, according to results of a study recently reported in JAMA (2006; 296:2319-28). 2006-11-16T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/462006/385981null HTML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/Company-submits-NDA-for-once-daily-OAB-drug/ArticleStandard/Article/detail/379726?contextCategoryId=9397&ref=25 Indevus Pharmaceuticals, Inc. has submitted a new drug application to the FDA seeking approval for a once-daily formulation of trospium chloride (Sanctura XR) to treat patients with overactive bladder. 2006-10-19T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/422006/379726null HTML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/North-American-data-Autologous-cells-show-promise-/ArticleStandard/Article/detail/381336?contextCategoryId=9397&ref=25 Pittsburgh—North America has now entered the competition to treat urinary incontinence with autologous muscle-derived cells with a human trial in seven patients. The prize is actual reconstruction of continence mechanisms. 2006-10-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/432006/381336null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Stem-cells-cure-80-of-patients-with-incontinence/ArticleStandard/Article/detail/381345?contextCategoryId=9397&ref=25 Innsbruck, Austria—Stem-cell repair of the body is an exciting prospect and a dream for medicine's future. But in Austria, the future is now. 2006-10-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/432006/381345/ut101506_01___10612_thumbnail.gif http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/432006/381345null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Marrow-stem-cells-used-to-regenerate-bladder-funct/ArticleStandard/Article/detail/381337?contextCategoryId=9397&ref=25 Atlanta—Marrow stem cells may one day be used to cure incontinence by reconstructing the sphincter, new research from Germany suggests. 2006-10-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/432006/381337null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Second-sling-after-failure-found-efficacious-safe/ArticleStandard/Article/detail/377471?contextCategoryId=9397&ref=25 Atlanta—Minimally invasive slings can work in women with stress urinary incontinence, even after a sling has failed. A key to success may be a higher presurgical Valsalva leak-point pressure. 2006-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/402006/377471null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Incontinence-survey-data-differ-from-medical-recor/ArticleStandard/Article/detail/377470?contextCategoryId=9397&ref=25 Atlanta—Undiagnosed urinary incontinence may occur in up to half of adult women age 25 to 80 years, according to a survey sent to patients at Kaiser Permanente Northwest Health Maintenance Organization, Portland, OR. 2006-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/402006/377470null XML http://urologytimes.modernmedicine.com/urologytimes/Enews/Bulking-agent-for-female-SUI-receives-approvable-l/ArticleStandard/Article/detail/373645?contextCategoryId=9397&ref=25 Uroplasty, Inc. has received an approvable letter from the FDA relating to its pre-market approval application for Macroplastique implants for the treatment of female stress urinary incontinence. 2006-09-21T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/382006/373645null HTML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Reducing-the-risk-of-incontinence-after-childbirth/ArticleStandard/Article/detail/367652?contextCategoryId=9397&ref=25 The choice of vaginal versus cesarean delivery has important implications for pelvic floor pathology later in the mother's life. But should urologists advocate elective cesarean delivery for all women in an effort to reduce the risk of SUI? 2006-09-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/conturo/342006/367652null XML http://urologytimes.modernmedicine.com/urologytimes/Urinary+Incontinence%2FOveractive+Bladder/New-male-sling-designed-to-help-prostate-cancer-su/ArticleStandard/Article/detail/365836?contextCategoryId=9397&ref=25 American Medical Systems Holdings, Inc. added the AdVance Male Sling to its line of male continence products. 2006-08-16T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/332006/365836null HTML http://urologytimes.modernmedicine.com/urologytimes/Enews/Three-questions-may-help-distinguish-stress-urge-i/ArticleStandard/Article/detail/362745?contextCategoryId=9397&ref=25 A three-question, noninvasive test appears to accurately classify stress and urge incontinence, according to a study in the Annals of Internal Medicine (2006; 144:715-23). 2006-08-03T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/312006/362745null HTML http://urologytimes.modernmedicine.com/urologytimes/Enews/FDA-approves-two-devices-for-treatment-of-OAB/ArticleStandard/Article/detail/362738?contextCategoryId=9397&ref=25 The FDA has granted approval to two devices indicated for the treatment of overactive bladder. 2006-08-03T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/312006/362738null HTML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Double-vs-single-cuff-AUS-Similar-long-term-outcom/ArticleStandard/Article/detail/364405?contextCategoryId=9397&ref=25 Atlanta—A study of patients receiving a double-cuff artificial urinary sphincter (AUS) shows encouraging short-term outcomes, but a second, longer-term study comparing single-cuff and double-cuff AUS indicates comparable outcomes but a greater complication rate with the double-cuff version. 2006-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/322006/364405null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Sling-shows-efficacy-in-male-stress-incontinence/ArticleStandard/Article/detail/364404?contextCategoryId=9397&ref=25 Atlanta—The transobturator approach for sling placement may result in decreased pad use and overall patient satisfaction in men with stress urinary incontinence, according to the preliminary findings of a small study presented by Peter Rehder, MD, a urologist at the University of Innsbruck, Austria. The data were reported at the AUA annual meeting here. 2006-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/322006/364404null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Sling-procedure-shows-efficacy-in-5-year-follow-up/ArticleStandard/Article/detail/364403?contextCategoryId=9397&ref=25 Atlanta—A sling procedure for women with stress urinary incontinence known as the distal urethral polypropylene sling (DUPS) procedure results in minimal complications and produces long-lasting results, according to 5-year results presented here at the AUA annual meeting. 2006-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/322006/364403null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Complications-from-sling-surgery-are-under-reporte/ArticleStandard/Article/detail/364402?contextCategoryId=9397&ref=25 Atlanta—Sling procedures have long been touted as minimally invasive approaches to stress urinary incontinence, but new data from UCLA suggest that complications resulting from sling surgery may happen far more frequently than is reported in the literature. 2006-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/322006/364402null XML http://www.modernmedicine.com/modernmedicine/Urinary+Incontinence%2FOveractive+Bladder/Female-stress-urinary-incontinence-Update-on-a-sim/ArticleStandard/Article/detail/361432?contextCategoryId=9397&ref=25 In the authors' hands, the distal urethral polypropylene sling (DUPS) procedure for female SUI is a simple and inexpensive technique that eliminates the need for costly prepackaged slings. Intermediate results suggest that it is safe, effective, and durable as well. 2006-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/conturo/302006/361432/CNTUR0806_CV1_10033_thumbnail.jpg http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/conturo/302006/361432null XML